Top Feature

Jul 07, 2017
Pharmaceutical Executive
David Keane outlines four best practices in implementing AI-based technology to help achieve physician-engagement wins.
Jun 28, 2017
Pharmaceutical Executive
Pharm Exec's 17th annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
Jun 19, 2017
By Pharmaceutical Executive Editors
There is never a lack of legal or regulatory issues to keep track of—and worry about—in the life sciences industry. The articles from Pharmaceutical Executive provide a look at the latest in compliance for marketing, labeling, and export control, as well as offer tips to stay compliant in the coming years.
Jun 12, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
A panel of biopharma executives discuss market access and the changing dynamics in reaching physicians and healthcare professionals.
Jun 12, 2017
Pharmaceutical Executive
With the patient voice growing louder in all aspects of the drug development and commercialization journey, Pharm Exec examines some of the current industry thinking on the evolving pharma-patient relationship.
Jun 12, 2017
Pharmaceutical Executive
An honoree at HBA’s recent Women of the Year awards luncheon, Bahija Jallal’s story is one of courage and resilience.
Jun 08, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
In its 11th annual feature, Pharm Exec breaks from the norm to instead profile five products that are currently shining the spotlight on critical and highly debated aspects of healthcare and R&D.
May 17, 2017
Pharmaceutical Executive
With this year marking our 11th installment, we look back on Pharm Exec's first 10 Brands of the Year.
May 12, 2017
Pharmaceutical Executive
For pharma, diagnosing what ails or strengthens performance in this critical corporate discipline may help reshape business prognosis.
May 09, 2017
Pharmaceutical Executive
Study examines why a pharma brand’s early sales are not a trusted predictor for total lifetime value—it’s about driving waves of growth.
native1_300x100
lorem ipsum